Rybelsus is convenient as an oral medication, but potential side effects like nausea, vomiting , and gastrointestinal issues should be considered
Unnikrishnan, CEO and Chief of Endocrinology at the Chellaram Diabetes Institute, Pune, noted, In an important news from the SOUL trial, oral semaglutide has shown it can reduce the risk of major adverse cardiovascular events (MACE), regardless of whether participants were already using sodium-glucose cotransporter-2 inhibitor (SGLT2i)
Regular mood check-ins during dose escalation help distinguish medication effects from weight-loss adjustment
Previously identified FBF partners include NOS-3, a Nanos homolog which is expressed throughout the germline [67, 68], and CPEB/CPB-1, which is expressed and functions in spermatocytes [64, 69]
1 2 3 SeungAh Lee, Dong Yun Lee: Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes